Highlights
ASX: DXB       DIMERIX LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.093   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):82,075
4 Weeks Range:0.087 - 0.105
4 Weeks Price Volatility (%):
88.57%
52 Weeks Range:0.072 - 0.15
52 Weeks Price Volatility (%):
62.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Dimerix Limited, formerly Sun Biomedical Limited, is clinical-stage biotechnology company, which is focused on developing therapeutics discovered using its drug development platform, Receptor-Heteromer Investigation Technology (HIT). The Company's principal activity is the development of its DMX-200 clinical asset for the treatment of chronic kidney disease and the commercialization of its underlying drug discovery technology. The Company's business segments are the development of occupational drug testing devices and new therapeutic agents in Australia, and clinical-stage drug discovery and development in Australia. Its DMX-200 is a combination of two existing drugs: irbesartan and propagermanium. DMX-200 is in Phase II clinical trials. It also has additional programs in its pipeline, including therapeutic candidates for treatment of Nonalcoholic Steatohepatitis (NASH) (fatty liver disease), Ocular diseases, Cancer fatigue and Multiple sclerosis.

  Be the first to like this.
 


 

11152 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAC 1.010.00 
 TPO 0.090.00 
 NCMLOD 2.020.00 
 NCMLOF 3.300.00 
 AAJ 0.0050.00 
 WPLKOV 4.350.00 
 AAR 0.0660.00 
 VMX 0.320.00 
 AAU 0.0090.00 
 MPL 3.370.00 
Partners & Brokers